Drugs / Zhengyuan Capsules
last change May 2024 re-read 3 minutes ago

Zhengyuan Capsules

Investigated by
Qiang Fu · Yangtze River Pharmaceutical Group Co., Ltd.

Trials 1

202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06381557 May 2024 → Mar 2027 expected — Qiang Fu Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Zhengyuan Capsules ClinicalTrials.gov intervention name — accepted as the source's own label NCT06381557 ↗